D Kokossis, H J Wei, M Gallitto, N Yoh, N McQuillan, M Tazhibi, X Berg, X Zhang, L Szalontay, R Gartrell, P Jovana, Z Zhang, A Molotkov, A Mintz, E E Konofagou, C C Wu
PURPOSE/OBJECTIVE(S): Diffuse midline glioma with H3K27 mutation is a fatal pediatric brain tumor, most commonly arising in the brainstem. This tumor remains universally fatal, despite a multitude of clinical trials, with a median overall survival of only 9-12 months. While immune-checkpoint inhibitors (ICIs) have transformed the treatment landscape of multiple solid tumors, delivery past the blood brain barrier (BBB) remains challenging. Programmed cell death protein 1 (PD1) is an immune checkpoint protein expressed on the surface of activated T cells; interaction with its ligand, PDL1, is tumor-protective, dampening T cell response...
October 1, 2023: International Journal of Radiation Oncology, Biology, Physics